Alto Neuroscience 8-K: Agreements, Sales, and Other Events

Ticker: ANRO · Form: 8-K · Filed: 2025-10-20T00:00:00.000Z

Sentiment: neutral

Topics: material-agreement, equity-sale, corporate-action

TL;DR

Alto Neuroscience 8-K: Material agreements entered & terminated, unregistered equity sales. Keep an eye on this.

AI Summary

Alto Neuroscience, Inc. filed an 8-K on October 20, 2025, reporting on events as of October 19, 2025. The filing indicates the entry into and termination of material definitive agreements, unregistered sales of equity securities, and other events, including financial statements and exhibits. The company is incorporated in Delaware and its principal executive offices are located in Mountain View, California.

Why It Matters

This 8-K filing by Alto Neuroscience signals significant corporate actions, including potential changes in agreements and equity transactions, which could impact its operational and financial standing.

Risk Assessment

Risk Level: medium — The filing mentions termination of material definitive agreements and unregistered sales of equity securities, which can indicate potential financial or strategic shifts that warrant closer examination.

Key Players & Entities

FAQ

What specific material definitive agreements were entered into and subsequently terminated by Alto Neuroscience?

The filing indicates the entry into and termination of material definitive agreements, but the specific details of these agreements are not provided in the excerpt.

What were the circumstances surrounding the unregistered sales of equity securities?

The filing notes unregistered sales of equity securities, but the excerpt does not provide details on the nature, volume, or recipients of these sales.

What 'Other Events' are being reported by Alto Neuroscience in this 8-K filing?

The filing lists 'Other Events' as a category, but the specific nature of these events is not detailed in the provided text.

What is the significance of the financial statements and exhibits being included in this filing?

The inclusion of financial statements and exhibits suggests that the company is providing updated financial information or supporting documentation related to the reported events.

When was Alto Neuroscience, Inc. incorporated, and what is its principal business address?

Alto Neuroscience, Inc. was incorporated in Delaware and its principal executive offices are located at 650 Castro St, Suite 450, Mountain View, CA 94041.

From the Filing

0001104659-25-100801.txt : 20251020 0001104659-25-100801.hdr.sgml : 20251020 20251020160159 ACCESSION NUMBER: 0001104659-25-100801 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20251019 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement ITEM INFORMATION: Unregistered Sales of Equity Securities ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251020 DATE AS OF CHANGE: 20251020 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41944 FILM NUMBER: 251403806 BUSINESS ADDRESS: STREET 1: 650 CASTRO STREET, SUITE 450 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 650 CASTRO STREET, SUITE 450 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94041 8-K 1 tm2529007d1_8k.htm FORM 8-K false 0001999480 0001999480 2025-10-19 2025-10-19 iso4217:USD xbrli:shares iso4217:USD xbrli:shares     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549       FORM  8-K       CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (Date of earliest event reported): October 19, 2025       ALTO NEUROSCIENCE, INC. (Exact Name of Registrant as Specified in its Charter)       Delaware     001-41944   83-4210124 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (IRS Employer Identification No.)   650 Castro St, Suite 450 , Mountain View , CA 94041 (Address of principal executive offices) (Zip Code)   Registrant’s telephone number, including area code: ( 650 ) 200-0412   N/A (Former name or former address, if changed since last report.)       Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))   Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common Stock, $0.0001 par value per share   ANRO   New York Stock Exchange   Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company x   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨           Item 1.01 Entry Into A Material Definitive Agreement.   Private Placement of Common Stock and Warrants   On October 19, 2025, Alto Neuroscience, Inc. (the “ Company ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain institutional and other accredited investors

View on Read The Filing